Gilead has struck a licensing agreement with five generic drugmakers around the globe
- deal is to make antiviral drug remdesivir in 127 countries
- deal is “royalty-free” until WHO says the Covid-19 outbreak is no longer a global health crisis or “until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19.”
Back in mid-April I posted the breaking the news on this:
- Early data on Gilead coronavirus medicine remdesivir is very encouraging
The news prompted swings not only in stocks but also in other markets (FX of course) . Since then there have been various updates, it works, it doesn’t, the usual. Much of of it ill-informed (again, the usual).
Anyway, the latest is this licensing agreement for the drug. Beats drinking bleach I guess.
Here you go, the recipe! (via Wikipedia if memory serves)